Abstract
The aim of this work is to describe the techniques that have been used for preparation and analysis of whole fetal liver extracts destined for in utero transplantation. Nine fetal livers between 12 and 17 weeks of gestation were prepared: cell counts and assessment of the hematopoietic cell viability were performed on cell suspensions. Hepatocytes represented 40 to 80% of the whole cell population. The remaining cells were constituted by hematopoietic cells (mainly erythroblasts), as well as by endothelial cells. The latter expressed CD34 on their surface, interfering with the assessment of CD34+ hematopoietic cells by flow cytometry. Direct visual morphologic control using alkaline phosphatase anti-alkaline phosphatase techniques was needed to differentiate hematopoietic from extra-hematopoietic CD34+ cells. Between 3.0 and 34.6 × 106 CD34+ viable hematopoietic cells were collected per fetal liver. Adequate differentiation of these cells into burst-forming units erythroid (BFU-E), colony-forming units granulocyte–macrophage (CFU-GM), and colony-forming units granulocyte erythroid macrophage megakaryocyte (CFU-GEMM) has been shown for each sample in clonogeneic cultures. In conclusion, fetal liver is a potential source of hematopoietic stem cells. Their numeration, based on the presence of CD34, is hampered by the expression of this antigen on other cells contained in the liver cell extract, in particular endothelial cells. Bone Marrow Transplantation (2000) 26, 667–671.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Touraine JL, Raudrant D, Laplace S . Transplantation of hematopoietic cells from the fetal liver to treat patients with congenital diseases postnatally or prenatally Transplant Proc 1997 29: 712–713
Péault B, Touraine JL, Charbord P . Hematopoietic stem cell emergence and development in the human embryo and fetus; perspectives for blood cell therapies in utero Semin Neonatol 1999 4: 55–66
Flake AW . In utero stem cell transplantation for the treatment of genetic diseases Schweiz Med Wochenschr 1999 129: 1733–1739
Gluckman E . The therapeutic potential of fetal and neonatal hematopoietic stem cells New Engl J Med 1996 335: 1839–1840
Forestier F . Greffe de foie fetal in utero Méd et Hyg 1997 55: 950–956
Fukuda T . Fetal hemopoiesis. II. Electron microscopic studies on human hepatic hemopoiesis Virchows Arch B Cell Pathol 1974 16: 249–270
Timens W, Kamps WA, Rozeboom-Uiterwijk T et al. Hemopoiesis in human fetal and embryonic liver Virch Arch A Pathol Anat Histopathol 1990 416: 429–436
Ek S, Ringden O, Markling L et al. Effects of cryopreservation on subsets of fetal liver cells Bone Marrow Transplant 1993 11: 395–398
Muench MO, Cupp J, Polakoff J, Roncarolo MG . Expression of CD33, CD38, and HLA-DR on CD34+ human fetal liver progenitors with a high proliferative potential Blood 1994 83: 3170–3181
Muench MO, Roncarolo MG, Namikawa R . Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver Blood 1997 89: 1364–1375
Roy V, Miller JS, Verfaillie CM . Phenotypic and functional characterisation of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver Exp Hematol 1997 25: 387–394
Kilpatrick DC, Atkinson AP, Palmer JB et al. Developmental variation in stem cell markers from human fetal liver and umbilical cord blood leukocytes Transfus Med 1998 8: 103–109
Opie TM, Shields LE, Andrews RG . Cell-surface antigen expression in early and term gestation fetal hematopoietic progenitor cells Stem Cells 1998 16: 343–348
Nicolini FE, Holyoake TL, Cashman JD et al. Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice Blood 1999 8: 2686–2695
Golfier F, Barcena A, Cruz J et al. Mid-trimester fetal livers are a rich source of CD34+/++ cells for transplantation Bone Marrow Transplant 1999 24: 451–461
Touraine JL . Induction of transplantation tolerance in humans using stem cell transplants prenatally or postnatally Transplant Proc 1999 31: 2735–2737
Ek S, Ringden O, Markling L, Westgren M . Immunological capacity of human fetal liver cells Bone Marrow Transplant 1994 14: 9–14
Huang S, Terstappen LWMM . Lymphoid and myeloid differentiation of single human CD34+, HLA−, DR+, CD38− hematopoietic cells Blood 1994 83: 1515–1526
Pawliuk R, Eaves C, Humphries RK . Evidence of both ontogeny and transplant dose-regulated expansion of hematopoietic stem cells in vivo Blood 1996 88: 2852–2858
Flake AW, Harrison MR, Adzick NS, Zanjani ED . Transplantation of fetal hematopoietic stem cells in utero: the creation of hematopoietic chimeras Science 1986 233: 776–778
Bataillard A, Vincent M, Sassard J, Touraine JL . Fetal liver cell transplantation fails to transfer hypertension from genetically hypertensive rats to normotensive rats of the Lyon strain J Hypertens 1991 9: 85–90
Combleholme TM, Langer JC, Harrison MR, Zanjani ED . Transplantation of fetal cells Am J Obstet Gynecol 1991 164: 218–230
Roncarolo MG, Vandekerckhove B . SCID-hu mice as a model to study tolerance after fetal stem cell transplantation Bone Marrow Transplant 1992 9: (Suppl. 1) 83–84
Roncarolo MG, Bacchetta R . T cell repertoire and tolerance after fetal stem cell transplantation Bone Marrow Transplant 1992 9: (Suppl. 1) 127–128
Bethel CAI, Muragesh D, Harrison MR et al. Fetal hematopoietic stem cell transplantation into beta-thalassemic mice J Pediatr Surg 1993 28: 1232–1238
Carrier E, Lee TH, Busch MP, Cowan MJ . Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells Blood 1995 86: 4681–4690
Omori N, Omori M, Evarts RP et al. Partial cloning of rat CD34 cDNA and expression during stem cell-dependent liver regeneration in the adult rat Hepatology 1997 26: 720–727
Fina L, Molgaatd H, Robertson D et al. Expression of CD34 gene in vascular endothelial cells Blood 1990 75: 2417–2426
Young PE, Baumhueter S, Lasky LA . The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development Blood 1995 85: 96–105
Shi Q, Rafii S, Wu MHD et al. Evidence for circulating bone marrow-derived endothelial cells Blood 1998 92: 362–367
Eichmann A, Corbel C, Nataf V et al. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2 Proc Natl Acad Sci USA 1997 94: 5141–5146
Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis Science 1997 275: 964–967
Bhatia M, Bonnet D, Murdoch B et al. A newly discovered class of human hematopoietic cells with SCID-repopulating activity Nature Med 1998 4: 1038–1045
Nakauchi H . Hematopoietic stem cells: are they CD34-positive or CD34-negative? Nature Med 1998 4: 1009–1010
Sato T, Laver JH, Ogawa M . Reversible expression of CD34 by murine hematopoietic stem cells Blood 1999 94: 2548–2554
Acknowledgements
The authors would like to thank Prof O Spertini and MS Quarroz for their kind advice and lending of the laboratory facilities.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zwicky, C., Gerber, S., Gasparini, D. et al. Preparation and analysis of fetal liver extracts. Bone Marrow Transplant 26, 667–671 (2000). https://doi.org/10.1038/sj.bmt.1702564
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702564